DexCom, Inc.

Healthcare

NASDAQ:DXCM · NASDAQ Global Select

Market Cap $29.08B Beta 1.44 P/E (TTM) 31.2

$75.37 +0.16%

+$0.12 today

52W Low $54.11High $89.98

Vol 4.67M · Avg 5.41M

EPS (TTM)$2.42

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-8.07%

Period High

$89.53

Period Low

$54.84

Latest

$75.37

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Teva Pharmaceutical Industries Limited

NYSE:TEVA

$40.32B

Biogen Inc.

NASDAQ:BIIB

$29.53B

Koninklijke Philips N.V.

NYSE:PHG

$25.70B

West Pharmaceutical Services, Inc.

NYSE:WST

$23.23B

Waters Corporation

NYSE:WAT

$23.17B

Labcorp Holdings Inc.

NYSE:LH

$21.83B

STERIS plc

NYSE:STE

$20.26B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

$17.13B

Smith & Nephew plc

NYSE:SNN

$12.97B

Insulet Corporation

NASDAQ:PODD

$10.37B

What is the latest DXCM filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does DXCM have?

Intrinsic Alpha currently shows 20 recent filings for DXCM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.